logo
Realme GT 7, 7T, and Buds Air 7 Pro go on sale with introductory offers

Realme GT 7, 7T, and Buds Air 7 Pro go on sale with introductory offers

Starting at Rs 34,999, the Realme GT 7 series features a 7,000mAh battery, AI-powered creative tools, and a suite of gaming enhancements
New Delhi
The Realme GT 7 series is now available for purchase in India, starting at Rs 34,999 for the GT 7T and Rs 39,999 for the GT 7. The smartphones are available on Realme's official website, select e-commerce platforms, and at select retail outlets. Alongside the smartphones, Realme Buds Air 7 Pro is also now available for purchase. Check details below:
Realme GT 7 series: Price and variants
Realme GT 7
8GB + 256GB: Rs 39,999
12GB + 256GB: Rs 42,999
12GB + 512GB: Rs 46,999
Colours: Icesense Black, Icesense Blue
Realme GT 7T
8GB + 256GB: Rs 34,999
12GB + 256GB: Rs 37,999
12GB + 512GB: Rs 41,999
Colours: Icesense Black, Icesense Blue, Racing Yellow
Realme Buds Air 7 Pro
Price: Rs 5,499
Colours: Glory Beige, Fiery Red, Metallic Grey, Racing Green
Realme GT series: Availability and offers
The Realme GT 7 and GT 7T are now available via Realme's official website, Amazon, and select retail outlets. The Dream Edition variant will go on sale from June 13.
Introductory offers include:
Rs 3,000 bank discount on select cards
Exchange bonus of up to Rs 6,000
No-cost EMI for up to 9 months (online purchases)
Buyers purchasing from select retail outlets will receive a Realme Buds T110 at no additional cost.
The Realme Buds Air 7 Pro is available via Amazon, Flipkart, Myntra, and Realme's official website.
Realme GT 7: Specifications and features
Display: 6.78-inch AMOLED, HDR+, 6,000 nits peak brightness, 120Hz refresh rate
Processor: MediaTek Dimensity 9400e
RAM: Up to 12GB
Storage: Up to 512GB
Rear cameras: 50MP (Sony IMX906) primary + 8MP ultra-wide + 50MP telephoto
Front camera: 32MP
Battery: 7,000mAh, 120W wired fast charging, 7.5W reverse charging
OS: Android 15
Protection: IP69
Weight: 206g
Notable features include AI-powered productivity tools, gaming modes, and IceSense Graphene for efficient heat dissipation during intensive use.
Realme GT 7T: Specifications and features
Display: 6.8-inch AMOLED, HDR10+, 120Hz refresh rate
Processor: MediaTek Dimensity 8400
RAM: Up to 12GB
Storage: Up to 512GB
Rear cameras: 50MP (IMX896) primary + 8MP ultra-wide
Front camera: 32MP
Battery: 7,000mAh, 120W wired fast charging
OS: Android 15
Protection: IP69
Weight: 205g
Like the GT 7, the 7T also includes IceSense Graphene thermal management for sustained performance during prolonged usage.
Realme Buds Air 7 Pro: Features
Active Noise Cancellation: Up to 53dB
Dual DAC drivers, Hi-Res Audio certification
Battery life: Up to 48 hours
Bluetooth 5.4 connectivity
Noise cancellation up to 5000Hz
Gemini AI Assistant integration
Live voice translation
Face-to-face interpreter mode
AI-powered query support

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP
Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP

News18

time15 minutes ago

  • News18

Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP

Last Updated: According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. Influx Healthtech IPO Allotment: The initial public offering of Influx Healthtech has received a whopping 201.35 times subscription, indicating huge interest from investors. Investors are now eagerly awaiting its allotment even its latest GMP shows a strong 22.92% listing gains. The allotment of the Influx Healthtech IPO is expected to be finalised today, Monday, June 23, in the evening. Once the IPO allotment is finalised, investors will start receiving bank debit messages, most probably in the evening. They can also check their allotment status on the websites of the NSE as well as registrar Maashitla Securities Private Limited. The allotment is expected to be finalised in the evening today, Friday, June 20. The allotment status can be checked by following these steps: Step 1: Visit Maashitla Securities' portal — Step 2: Under 'Select Company', choose 'Influx Healthtech Ltd'. Importantly, if the company's name is not visible in the drop-down list, it means the allotment has not been finalised yet. According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Influx Healthtech IPO Listing Date The shares of Influx Healthtech Ltd will be listed on the NSE Emerge on June 25. The Influx Healthtech IPO was open for subscription between June 18 and June 20. It is a book-built issue worth Rs 58.57 crore, comprising a fresh issue of 50 lakh equity shares worth Rs 48 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. On the final day of bidding on Friday, the SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The price of the Influx Healthtech IPO was fixed at Rs 96 apiece. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.

Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…
Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…

India.com

time18 minutes ago

  • India.com

Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…

Anil Ambani was already in the news for settling down the debt of his many companies. Now once again it has settled the debt with another company. In a recent exchange filing it stated that it has fully settled a Rs 273-crore loan, including interest, owed by its wholly owned subsidiary JR Toll Road Pvt Ltd (JRTR) to Yes Bank Ltd. It stated, '' A wholly owned subsidiary of the Company (along with the Company as Corporate Guarantor), has entered into an addendum to the Settlement Agreement today with Yes Bank Limited (YBL) for the entire outstanding debt obligation of ~INR 273 crore (including interest) owed by JRTR to YBL, and has duly paid the entire settlement amount.'' Anil Ambani Company Debt Reduction Debt reduction has become a primary focus for Anil Ambani. Reliance Infrastructure: Paid off Rs 3,300 crore of debt in FY 2025, becoming debt-free. Rosa Power Supply Company: Cleared Rs 485 crore of debt, achieving debt-free status. Reliance Power: Settled a loan of Rs 3,872 crore earlier. JR Toll Road Pvt Ltd, a special purpose vehicle established by Reliance Infrastructure, is responsible for the development, operation, and maintenance of a 52-kilometer segment of National Highway 11, connecting Jaipur and Reengus in Rajasthan. The project was executed under the Design-Build-Finance-Operate-Transfer (DBFOT) model, featuring a highway expansion from four to six lanes. Operations commenced in 2013, coinciding with the start of toll collection.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store